CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
+7.64%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$649M
AUM Growth
+$38.4M
(+6.3%)
Cap. Flow
+$3.18M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
8.38%
Holding
684
New
103
Increased
174
Reduced
151
Closed
77
Top Buys
| 1 |
Applied Materials
AMAT
|
$2.73M |
| 2 |
Wells Fargo
WFC
|
$2.29M |
| 3 |
Lockheed Martin
LMT
|
$2.15M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
$2.05M |
| 5 |
S&P Global
SPGI
|
$2M |
Top Sells
| 1 |
CVS Health
CVS
|
$2.6M |
| 2 |
Broadcom
AVGO
|
$2.56M |
| 3 |
Parker-Hannifin
PH
|
$2.49M |
| 4 |
American Express
AXP
|
$2.36M |
| 5 |
Chubb
CB
|
$2.18M |
Sector Composition
| 1 | Financials | 18.76% |
| 2 | Technology | 17.7% |
| 3 | Healthcare | 14.05% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Zymeworks
ZYME
$1.14B
| $270K | 0.04% |
25,709
| – | – |
|
527
Kinder Morgan
KMI
$59.1B
| $270K | 0.04% |
14,706
-116
| -0.8% | -$2.13K |
|
528
Evercore
EVR
$12.3B
| $269K | 0.04% |
1,396
-13
| -0.9% | -$2.5K |
|
529
Fair Isaac
FICO
$36.8B
| $266K | 0.04% |
213
-1
| -0.5% | -$1.25K |
|
530
Amkor Technology
AMKR
$6.09B
| $266K | 0.04% |
8,255
| – | – |
|
|
DCPH
531
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $262K | 0.04% |
16,673
| – | – |
|
532
Automatic Data Processing
ADP
$120B
| $260K | 0.04% |
1,043
-9
| -0.9% | -$2.25K |
|
533
TopBuild
BLD
$12.3B
| $260K | 0.04% |
590
| – | – |
|
534
D.R. Horton
DHI
$54.2B
| $259K | 0.04% |
1,571
-41
| -3% | -$6.75K |
|
535
Regenxbio
RGNX
$490M
| $258K | 0.04% |
12,256
+354
| +3% | +$7.46K |
|
536
Cboe Global Markets
CBOE
$24.3B
| $255K | 0.04% |
1,387
-15
| -1% | -$2.76K |
|
|
PSTX
537
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $254K | 0.04% |
79,552
| – | – |
|
538
Acuity Brands
AYI
$10.4B
| $249K | 0.04% |
926
-2,614
| -74% | -$702K |
|
539
Rollins
ROL
$27.4B
| $247K | 0.04% |
5,335
| – | – |
|
540
Black Diamond Therapeutics
BDTX
$167M
| $247K | 0.04% |
48,629
-34,155
| -41% | -$173K |
|
541
Gray Television
GTN
$625M
| $243K | 0.04% |
38,488
+340
| +0.9% | +$2.15K |
|
542
Arcus Biosciences
RCUS
$1.3B
| $242K | 0.04% |
12,817
+30
| +0.2% | +$566 |
|
543
Hewlett Packard
HPE
$31B
| $242K | 0.04% |
13,626
-165
| -1% | -$2.93K |
|
544
Ultragenyx Pharmaceutical
RARE
$3.07B
| $241K | 0.04% |
5,161
+15
| +0.3% | +$700 |
|
545
Enanta Pharmaceuticals
ENTA
$189M
| $241K | 0.04% |
13,785
+249
| +2% | +$4.35K |
|
546
MacroGenics
MGNX
$126M
| $239K | 0.04% |
16,217
-12,893
| -44% | -$190K |
|
547
Eli Lilly
LLY
$652B
| $236K | 0.04% |
+304
| New | +$236K |
|
548
Installed Building Products
IBP
$7.44B
| $234K | 0.04% |
905
-3,374
| -79% | -$873K |
|
549
Cogent Biosciences
COGT
$1.82B
| $232K | 0.04% |
34,494
+166
| +0.5% | +$1.12K |
|
550
Vir Biotechnology
VIR
$732M
| $231K | 0.04% |
22,782
+10,320
| +83% | +$105K |
|